Evidence from a mouse model supports repurposing an anti-asthmatic drug, bambuterol, against Alzheimer’s disease by administration through an intranasal route
Abstract Bambuterol is a long-acting anti-asthmatic prodrug which releases terbutaline. Terbutaline is an agonist of the β2-adrenergic receptors which is formed by decarbamoylation of bambuterol by butyrylcholinesterase. Inhibition of the latter, as well as activation of β2-AR, are of interest for t...
Saved in:
Main Authors: | Anne-Claire Groo, Thomas Curel, Aurélie Malzert-Fréon, Line Séguy, Ophélie Bento, Sophie Corvaisier, Thomas Culerier, Romain Legrand, Noëlle Callizot, Alexandre Henriques, Georgia Culley, Sylvie Claeysen, Christophe Rochais, Patrick Dallemagne |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-025-07599-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Congenital Intranasal Glioma
by: Sajad Ahmad Salati, et al.
Published: (2011-01-01) -
Repurposing radiosensitising medicines for radiotherapy: an overview
by: Geoff S Higgins, et al.
Published: (2024-07-01) -
Alleviating effect of intranasal zinc on symptoms of allergic rhinitis
by: Huadong Xu, PhD, et al.
Published: (2025-05-01) -
Drug repurposing screen for the rare disease ataxia-telangiectasia
by: Namrata Jayanth, et al.
Published: (2025-01-01) -
Comparison of a ready-to-use intranasal dexmedetomidine spray with traditional intranasal dexmedetomidine drops for sedation in preschool children: a prospective, randomized, controlled study
by: Qi-Qi Jin, et al.
Published: (2025-01-01)